PPH VanEck Pharmaceutical ETF Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
18:33
Aug 05
Sarah Ketterer CEO and Fundamental Portfolio Manager, Causeway Capital Man… Bloomberg Markets
Pharma offers AI upside and defense.
Pharmaceuticals are an underappreciated AI beneficiary with yield and strong balance sheets, offering a defensive play at a time when AI-driven drug discovery could compress development timelines and enhance productivity significantly.
PPH 1ST
HIGH

About PPH Analyst Coverage

Buzzberg tracks PPH (VanEck Pharmaceutical ETF) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: Sarah Ketterer.